{
    "clinical_study": {
        "@rank": "46891", 
        "acronym": "OPINION", 
        "arm_group": [
            {
                "arm_group_label": "OFDI-guided PCI", 
                "arm_group_type": "Experimental", 
                "description": "OFDI-guided PCI and assessment by OFDI at pre-PCI and post-PCI\nFollow-up contact at the time of hospital discharge, 8 months and 12 months after PCI."
            }, 
            {
                "arm_group_label": "IVUS-guided PCI", 
                "arm_group_type": "Active Comparator", 
                "description": "IVUS-guided PCI and assessment by IVUS at pre-PCI and post-PCI\nFollow-up contact at the time of hospital discharge, 8 months and 12 months after PCI."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this randomized study is to evaluate the impact of Optical frequency domain\n      imaging (OFDI) guidance for Percutaneous Coronay Intervention (PCI) with drug-eluting stent\n      (DES) as compared with Intravascular ultrasound (IVUS) guidance."
        }, 
        "brief_title": "OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "Optical frequency domain imaging (OFDI) is a novel, high resolution intravascular imaging\n      modality. Intravascular ultrasound (IVUS) is a widely used conventional imaging modality for\n      achieving optimal stent deployment.\n\n      The aim of this randomized study is to evaluate the impact of OFDI guidance for Percutaneous\n      Coronay Intervention (PCI) with drug-eluting stent (DES) as compared with IVUS guidance.\n\n      We will enroll 800 patients with a de novo lesion who will undergo PCI with DES as is\n      routine practice. Patients will be rondomely assigned to either OFDI-guided PCI arm or\n      IVUS-guided PCI arm.\n\n      Patients will then have a follow-up contact at the time of hospital discharge, 8 month and\n      12 month after PCI."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with a de novo lesion (in the native coronary circulation) and planned to\n             undergo drug-eluting stent implantation for indications according to the Japan and\n             USA guidelines\n\n          -  Patients aged between 20 and 85 years old\n\n          -  Patients who has provided written informed consent\n\n        Exclusion Criteria:\n\n          -  Patients with Acute Myocardial Infarction (AMI) within 3 months\n\n          -  Patients with cardiogenic shock\n\n          -  Patients with chronic heart failure\n\n          -  Patients with renal failure (eGFR <= 30 ml/min/1.73 m2 or Serum creatinine level\n             >=1.5mg/dL)\n\n          -  Patients who are currently enrolled in other clinical trial which has possibility to\n             influence the primary endpoint of OPINION trial.\n\n          -  Patients planned use of bare metal stent\n\n          -  Patients with 3-vessel diseases\n\n          -  Planned surgery within 1 year\n\n          -  Patient on dialysis\n\n          -  Target lesion such as:\n\n               -  Left main coronary artery\n\n               -  Aorto-Ostial lesion location within 3mm of the aorta junction\n\n               -  Chronic total occlusion\n\n               -  Small vessel (reference vessel diameter <2.5mm)\n\n               -  Coronary artery bypass graft"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "800", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01873027", 
            "org_study_id": "TRICVD1225", 
            "secondary_id": "UMIN000010580"
        }, 
        "intervention": [
            {
                "arm_group_label": "OFDI-guided PCI", 
                "description": "OFDI-guided PCI and assessment by OFDI at pre-PCI and post-PCI\nFollow-up contact at the time of hospital discharge, 8 months and 12months after PCI", 
                "intervention_name": "OFDI", 
                "intervention_type": "Device", 
                "other_name": [
                    "LUNAWAVE", 
                    "Fastview", 
                    "Biolimus a9-eluting stent (Nobori stent)"
                ]
            }, 
            {
                "arm_group_label": "IVUS-guided PCI", 
                "description": "IVUS-guided PCI and assessment by IVUS at pre-PCI and post-PCI\nFollow-up contact at the time of hospital discharge, 8 months and 12months after PCI", 
                "intervention_name": "IVUS", 
                "intervention_type": "Device", 
                "other_name": [
                    "VISIWAVE", 
                    "ViewIT", 
                    "Biolimus A9-eluting stent (Nobori stent)"
                ]
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Coronary Artery Disease", 
            "Percutaneous Coronary Intervention", 
            "Optical Frequency Domain Imaging", 
            "Intravascular Ultrasound"
        ], 
        "lastchanged_date": "January 27, 2014", 
        "location": {
            "contact": {
                "email": "OPINION@tri-kobe.org", 
                "last_name": "Takashi Akasaka, MD. PhD", 
                "phone": "+81-73-441-0621"
            }, 
            "facility": {
                "address": {
                    "city": "Wakayama", 
                    "country": "Japan", 
                    "state": "Wakayama Prefecture", 
                    "zip": "641-8510"
                }, 
                "name": "Wakayama Medical University"
            }, 
            "investigator": {
                "last_name": "Takashi Akasaka, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "2", 
        "official_title": "OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON (OPINION)", 
        "overall_contact": {
            "email": "OPINION@tri-kobe.org", 
            "last_name": "Takashi Kubo, MD, PhD", 
            "phone": "+81-73-441-0621"
        }, 
        "overall_official": {
            "affiliation": "Wakayama Medical University", 
            "last_name": "Takashi Akasaka, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Japan: Ethics Committee of Wakayama Medical University", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The composite endpoint comprised of cardiac death, target vessel-related myocardial infarction (MI) and clinically-driven target vessel revascularization (TVR)", 
            "measure": "Target Vessel Failure (TVF)", 
            "safety_issue": "Yes", 
            "time_frame": "12 months after  PCI"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01873027"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Cardiac death", 
                "safety_issue": "Yes", 
                "time_frame": "12 months after PCI"
            }, 
            {
                "measure": "Myocardial Infarction (MI)", 
                "safety_issue": "Yes", 
                "time_frame": "12 months after PCI"
            }, 
            {
                "measure": "Clinically-driven Target lesion revascularization (TLR)", 
                "safety_issue": "No", 
                "time_frame": "12 months after PCI"
            }, 
            {
                "measure": "MACE (composite of cardiac death, MI, TLR)", 
                "safety_issue": "Yes", 
                "time_frame": "12 months after PCI"
            }, 
            {
                "measure": "Target Vessel Revascularization (TVR)", 
                "safety_issue": "No", 
                "time_frame": "12 months after PCI"
            }, 
            {
                "measure": "Stroke", 
                "safety_issue": "Yes", 
                "time_frame": "12 months after PCI"
            }, 
            {
                "measure": "Stent thrombosis", 
                "safety_issue": "Yes", 
                "time_frame": "12 months after PCI"
            }, 
            {
                "measure": "Binary restenosis", 
                "safety_issue": "No", 
                "time_frame": "12 months after PCI"
            }, 
            {
                "measure": "Renal dysfunction", 
                "safety_issue": "Yes", 
                "time_frame": "8 months after PCI"
            }
        ], 
        "source": "Translational Research Informatics Center, Kobe, Hyogo, Japan", 
        "sponsors": {
            "collaborator": {
                "agency": "Wakayama Medical University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Translational Research Informatics Center, Kobe, Hyogo, Japan", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}